Product image of Glucose-Lösung Deltamedica (Glucose) supplied by GNH India

Glucose-Lösung Deltamedica

Active Ingredient:
Glucose
Origin:
EU

Glucose-Lösung Deltamedica (Glucose)

Glucose-Lösung Deltamedica is an intravenous solution containing the carbohydrate glucose as its sole active ingredient. It is supplied as a sterile solution for injection, intended for parenteral administration in clinical settings across the EU. The product provides an immediate source of energy and helps maintain plasma osmolarity when delivered intravenously, supporting patients who require carbohydrate replacement or fluid balance management under medical supervision and monitoring.

Manufacturer / TM Owner

Deltamedica Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucose-Lösung Deltamedica is used in several clinical situations where rapid carbohydrate delivery or fluid replacement is required.

  • Treatment of acute hypoglycemia when oral glucose is not feasible.
  • Component of total parenteral nutrition (TPN) regimens for patients unable to receive enteral feeding.
  • Support of fluid and electrolyte balance during peri‑operative care.
  • Provision of an energy source during prolonged fasting or critical illness.
  • Adjunct in electrolyte replacement solutions to maintain osmotic stability.

Side Effects

Intravenous glucose solutions may be associated with a range of adverse reactions, most of which are related to the infusion rate or patient‑specific factors.

Common

  • Transient mild hyperglycemia.
  • Local irritation or pain at the infusion site.
  • Nausea or mild gastrointestinal discomfort.
  • Headache.
  • Electrolyte shifts such as mild hyponatremia.
  • Flushing or warmth sensation.

Serious

  • Severe hyperglycemia leading to osmotic diuresis.
  • Hypoglycemia after abrupt discontinuation of infusion.
  • Fluid overload or pulmonary edema.
  • Allergic or anaphylactoid reaction.
  • Hyperosmolar hyperglycemic state.
  • Severe electrolyte disturbances (e.g., hyperkalemia).

Precautions & Warnings

When administering Glucose-Lösung Deltamedica, clinicians should observe several safety considerations to minimize risk.

  • Verify patient’s blood glucose level before initiating therapy.
  • Adjust infusion rate in patients with renal or cardiac impairment.
  • Monitor serum electrolytes regularly during prolonged use.
  • Use aseptic technique to prevent catheter‑related infections.
  • Avoid rapid bolus administration unless specifically indicated.
  • Consider pregnancy status; data are limited, so use only if benefits outweigh risks.
  • Document infusion parameters and patient response in the medical record.

Avoid Interactions

Glucose-Lösung Deltamedica can interact with other medications or clinical conditions, requiring careful management.

Avoid

  • Concurrent administration of high‑dose insulin without glucose monitoring.
  • Co‑infusion with hypertonic saline solutions that may exacerbate hyperosmolarity.
  • Use in patients with uncontrolled diabetes mellitus.

Use with caution

  • Diuretics that may alter fluid balance.
  • Beta‑blockers that can mask hypoglycemia symptoms.
  • Corticosteroids, which can increase glucose production.
  • Catecholamine vasopressors that may affect glucose metabolism.
  • Nutritional formulas containing additional carbohydrates.

Frequently Asked Questions

It provides an immediate source of glucose for energy and helps maintain plasma osmolarity when administered intravenously.

It is commonly used for acute hypoglycemia, as part of total parenteral nutrition, during peri‑operative fluid management, and for energy support in prolonged fasting.

The product is supplied as a sterile solution for injection and is given intravenously, usually via a controlled infusion pump.

Blood glucose levels, serum electrolytes, and fluid balance should be monitored regularly, especially during prolonged therapy.

Pregnancy safety data are limited; it should only be used when the potential benefit justifies any potential risk to the fetus.

Common reactions include mild hyperglycemia, local infusion site irritation, nausea, headache, and minor electrolyte shifts.

Severe hyperglycemia, fluid overload, allergic reactions, hyperosmolar hyperglycemic state, and significant electrolyte disturbances require urgent evaluation.

It can be combined with compatible electrolyte solutions, but mixing with hypertonic or incompatible fluids should be avoided.

Infection risk is related to catheter use; strict aseptic technique and proper line care are essential to minimize infection.

Intravenous administration bypasses gastrointestinal absorption, providing rapid glucose delivery directly into the bloodstream, which is essential when oral intake is not possible.

The infusion should be slowed or stopped, and insulin therapy may be initiated under medical supervision while monitoring glucose closely.

Use in children should follow pediatric dosing guidelines and be supervised by a pediatric specialist.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glucose

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT